Title: Role of HER2/HER3 other signalling pathways and the ability of AZD8931 to inhibit the growth of EGFR responsive anti-hormone-resistant breast cancer lines

Funder
AstraZeneca UK Ltd

Principal Investigator
None Yet Associated

Co-Investigators
Gee, Julia

Project Details
Net value award figure for Cardiff University: £205,525.00
Start date: 01/09/2009
End date: 31/03/2012

Last updated on 2021-16-01 at 06:01